Advisory Committee on Infant Mortality; Notice of Meeting, 29161 [E6-7662]

Download as PDF Federal Register / Vol. 71, No. 97 / Friday, May 19, 2006 / Notices Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Written comments should be received within 60 days of this notice. Dated: May 15, 2006. Tina Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. E6–7667 Filed 5–18–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration wwhite on PROD1PC61 with NOTICES Advisory Committee on Infant Mortality; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Infant Mortality (ACIM). Dates and Times: July 13, 2006, 9 a.m.–5 p.m.; July 14, 2006, 8:30 a.m.–3 p.m. Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209, (703) 524–6400. Status: The meeting is open to the public with attendance limited to space availability. Purpose: The Committee provides advice and recommendations to the Secretary of Health and Human Services on the following: Department programs that are directed at reducing infant mortality and improving the health status of pregnant women and infants; factors affecting the continuum of care with respect to maternal and child health care, including outcomes following childbirth; strategies to coordinate the variety of Federal, State, local and private programs and efforts that are designed to deal with the health and social problems impacting on infant mortality; and the implementation of the Healthy Start program and Healthy People 2010 infant mortality objectives. Agenda: Topics that will be discussed include the following: Preterm birth; Medicaid Policy; Pregnancy Weight; and the Perinatal and Patient Safety Pilot Program. Substantial time will be spent in Subcommittee and full Committee discussions aimed at formulating the ACIM issues agenda. Proposed agenda items are subject to change as priorities indicate. Time will be provided for public comments limited to five minutes each; VerDate Aug<31>2005 17:37 May 18, 2006 Jkt 208001 comments are to be submitted no later than June 19, 2006. For Further Information Contact: Anyone requiring information regarding the Committee should contact Peter C. van Dyck, M.D., M.P.H., Executive Secretary, ACIM, Health Resources and Services Administration (HRSA), Room 18–05, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (301) 443–2170. Individuals who are submitting public comments or who have questions regarding the meeting and location should contact Michelle Loh, HRSA, Maternal and Child Health Bureau, telephone: (301) 443–0543, e-mail: michelle.loh@hrsa.hhs.gov. Dated: May 15, 2006. Tina M. Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. E6–7662 Filed 5–18–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Vaccine Injury Compensation Program; List of Petitions Received Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: SUMMARY: The Health Resources and Services Administration (HRSA) is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (‘‘the Program’’), as required by section 2112(b)(2) of the Public Health Service (PHS) Act, as amended. While the Secretary of Health and Human Services is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions. FOR FURTHER INFORMATION CONTACT: For information about requirements for filing petitions, and the Program in general, contact the Clerk, United States Court of Federal Claims, 717 Madison Place, NW., Washington, DC 20005, (202) 357–6400. For information on HRSA’s role in the Program, contact the Director, National Vaccine Injury Compensation Program, 5600 Fishers Lane, Room 11C–26, Rockville, MD 20857; (301) 443–6593. SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 29161 compensation for certain individuals who have been injured by specified childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 300aa– 10 et seq., provides that those seeking compensation are to file a petition with the U.S. Court of Federal Claims and to serve a copy of the petition on the Secretary of Health and Human Services, who is named as the respondent in each proceeding. The Secretary has delegated his responsibility under the Program to HRSA. The Court is directed by statute to appoint special masters who take evidence, conduct hearings as appropriate, and make initial decisions as to eligibility for, and amount of, compensation. A petition may be filed with respect to injuries, disabilities, illnesses, conditions, and deaths resulting from vaccines described in the Vaccine Injury Table (the Table) set forth at section 2114 of the PHS Act or as set forth at 42 CFR 100.3, as applicable. This Table lists for each covered childhood vaccine the conditions which may lead to compensation and, for each condition, the time period for occurrence of the first symptom or manifestation of onset or of significant aggravation after vaccine administration. Compensation may also be awarded for conditions not listed in the Table and for conditions that are manifested outside the time periods specified in the Table, but only if the petitioner shows that the condition was caused by one of the listed vaccines. Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa–12(b)(2), requires that the Secretary publish in the Federal Register a notice of each petition filed. Set forth below is a list of petitions received by HRSA on January 1, 2006, through March 31, 2006. Section 2112(b)(2) also provides that the special master ‘‘shall afford all interested persons an opportunity to submit relevant, written information’’ relating to the following: 1. The existence of evidence ‘‘that there is not a preponderance of the evidence that the illness, disability, injury, condition, or death described in the petition is due to factors unrelated to the administration of the vaccine described in the petition,’’ and 2. Any allegation in a petition that the petitioner either: (a) ‘‘Sustained, or had significantly aggravated, any illness, disability, injury, or condition not set forth in the Table but which was caused by’’ one of the vaccines referred to in the Table, or (b) ‘‘Sustained, or had significantly aggravated, any illness, disability, injury, or condition set forth in the E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 71, Number 97 (Friday, May 19, 2006)]
[Notices]
[Page 29161]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7662]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Infant Mortality; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), notice is hereby given of the 
following meeting:
    Name: Advisory Committee on Infant Mortality (ACIM).
    Dates and Times: July 13, 2006, 9 a.m.-5 p.m.; July 14, 2006, 8:30 
a.m.-3 p.m.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209, 
(703) 524-6400.
    Status: The meeting is open to the public with attendance limited 
to space availability.
    Purpose: The Committee provides advice and recommendations to the 
Secretary of Health and Human Services on the following: Department 
programs that are directed at reducing infant mortality and improving 
the health status of pregnant women and infants; factors affecting the 
continuum of care with respect to maternal and child health care, 
including outcomes following childbirth; strategies to coordinate the 
variety of Federal, State, local and private programs and efforts that 
are designed to deal with the health and social problems impacting on 
infant mortality; and the implementation of the Healthy Start program 
and Healthy People 2010 infant mortality objectives.
    Agenda: Topics that will be discussed include the following: 
Preterm birth; Medicaid Policy; Pregnancy Weight; and the Perinatal and 
Patient Safety Pilot Program. Substantial time will be spent in 
Subcommittee and full Committee discussions aimed at formulating the 
ACIM issues agenda. Proposed agenda items are subject to change as 
priorities indicate.
    Time will be provided for public comments limited to five minutes 
each; comments are to be submitted no later than June 19, 2006.
    For Further Information Contact: Anyone requiring information 
regarding the Committee should contact Peter C. van Dyck, M.D., M.P.H., 
Executive Secretary, ACIM, Health Resources and Services Administration 
(HRSA), Room 18-05, Parklawn Building, 5600 Fishers Lane, Rockville, MD 
20857, Telephone: (301) 443-2170.
    Individuals who are submitting public comments or who have 
questions regarding the meeting and location should contact Michelle 
Loh, HRSA, Maternal and Child Health Bureau, telephone: (301) 443-0543, 
e-mail: michelle.loh@hrsa.hhs.gov.

    Dated: May 15, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-7662 Filed 5-18-06; 8:45 am]
BILLING CODE 4165-15-P